Gene expression profiling in the rat cranial suture

Journal of Craniofacial Surgery

Volumn 16, Issue 3, 2005, Pages 378-388

  Law, Clarice S ^a,b,d   Warren, Stephen M ^a,c   Mehrara, Babak J ^a,d   Ting, Kang ^a,b  

^a University of California ^*

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d UCLA SCHOOL OF DENTISTRY   (United States)

Author keywords

Bone morphogenetic protein (BMP); Cranial suture biology; Cranial suture mesenchyme fibroblast growth factor (FGF); Growth factors; Transforming growth factor (TGF )

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 4; OSTEOGENIN; PROTEIN TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; PROTEIN TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; PROTEIN TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; TRANSCRIPTION FACTOR SAGA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CRANIAL SUTURE; CRANIOFACIAL SYNOSTOSIS; GENE EXPRESSION; MESENCHYME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SKULL DEVELOPMENT; SOUTHERN BLOTTING;

ANIMALS; BLOTTING, SOUTHERN; BONE MORPHOGENETIC PROTEINS; CRANIAL SUTURES; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION; GENE EXPRESSION PROFILING; IMMUNOBLOTTING; MESODERM; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GROWTH FACTOR; RESEARCH DESIGN; TRANSFORMING GROWTH FACTOR BETA;

EID: 20744458239     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.SCS.0000157018.27783.91     Document Type: Article

References (54)

1. Cohen MM Jr, MacLean RE. Craniosynostosis: Diagnosis, Evaluation, and Management. New York: Oxford University Press, Inc, 2000
2. Warren SM, Longaker MT. New directions in plastic surgery research. Clin Plast Surg 2001;28:719-730
3. Virchow R. Ueber den Cretinismus, namentlich in Franken, und ueber pathologische Schaedelformen. Verh Phys Med Gesellsch Wuerzburg 1851;2:231-271
4. Park EA, Powers GF. Acrocephaly and scaphocephaly with symmetrically distributed malformations of the extremities. Am J Dis Child 1920;20:235-315
5. Moss ML. The pathogenesis of premature cranial synostosis in man. Acta Anat 1959;37:351-370
6. Moss ML. Fusion of the frontal suture in the rat. Am J Anat 1958;102:141-166
7. Moss ML. Inhibition and stimulation of sutural fusion in the rat calvaria. Anat Rec 1960;136:457-467
8. Bradley JP, Levine JP, McCarthy JG, et al. Studies in cranial suture biology: regional dura mater determines in vitro cranial suture fusion. Plast Reconstr Surg 1997;100:1091-1099
9. Opperman LA, Nolen AA, Ogle RC. TGF-beta 1, TGF-beta 2, and TGF-beta 3 exhibit distinct patterns of expression during cranial suture formation and obliteration in vivo and in vitro. J Bone Miner Res 1997;12:301-310
10. Roth DA, Longaker MT, McCarthy JG, et al. Studies in cranial suture biology: Part I. Increased immunoreactivity for transforming growth factor-beta (β1, β2, β3) during rat cranial suture fusion. J Bone Miner Res 1997;12:311-321
11. Alberius P, Johnell O. Immunohistochemical assessment of cranial suture development in rats. J Anat 1990;173:61-68
12. Roth DA, Gold LI, Han VK, et al. Immunolocalization of transforming growth factor beta 1, beta 2, and beta 3 and insulin-like growth factor I in premature cranial suture fusion. Plast Reconstr Surg 1997;99:300-309
13. Wilkie AOM. Craniosynostosis: genes and mechanisms. Hum Mol Genet 1997;6:1647-1656
14. Zimmerman LB, De Jesus-Escobar JM, Harland RM. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 1996;86:599-606
15. Urist MR. Bone morphogenetic protein: the molecularization of skeletal system development. J Bone Miner Res 1997;12:343-346
16. Kim H, Rice D, Kettunen P, et al. FGF, BMP, and Shh mediated signaling pathways in the regulation of cranial suture morphogenesis and calvarial bone development. Development 1998; 125:1241-1251
17. Kimoto T, Hosokawa R, Kubo T, et al. Continuous administration of basic fibroblast growth factor (FGF-2) accelerates bone induction on rat calvaria-an application of a new drug delivery system. J Dent Res 1998;77:1965-1969
18. Nakamura K, Kawaguchi H, Aoyama I, et al. Stimulation of bone formation by intraosseous application of recombinant basic fibroblast growth factor in normal and ovariectomized rabbits. J Orthop Res 1997;15:307-313
19. Nakamura K, Kurokawa T, Kawaguchi H, et al. Stimulation of endosteal bone formation by local intraosseous application of basic fibroblast growth factor in rats. Rev Rheum Engl Ed 1997; 64:101-105
20. Jabs EW, Xiang L, Scott AD, et al. Jackson-Weiss and Crouzon syndromes are allelic with mutations in fibroblast growth factor receptor 2. Nat Genet 1994;8
21. Muenke M, Schell U, Hehr A, et al. A common mutation in the fibroblast growth factor receptor 1 gene in Pfeiffer syndrome. Nat Genet 1994;8:269-274
22. Muenke M, Gripp KW, McDonald-McGinn DM, et al. A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am J Hum Genet 1997;60:555-564
23. Reardon W, Winter RM, Rutland P, et al. Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nat Genet 1994;8:98-103
24. Wilkie AOM, Slaney SF, Oldridge M, et al. Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome. Nat Genet 1995;9:165-171
25. Most D, Levine JP, Chang J, et al. Studies in cranial suture biology: up-regulation of transforming growth factor-beta1 and basic fibroblast growth factor mRNA correlates with posterior frontal cranial suture fusion in the rat. Plast Reconstr Surg 1998; 101:1431-1440
26. Mehrara BJ, Most DE, Chang J, et al. Basic fibroblast growth factor and transforming growth factor beta-1 expression in the developing dura mater correlates with calvarial bone formation. Plast Reconstr Surg 1999;102:1805-1817
27. Centrella M, McCarthy TL, Canalis E. Mitogenesis in fetal rat bone cells simultaneously exposed to type beta transforming growth factor and other growth regulators. FASEB J 1987;1: 312-317
28. Harris SE, Bonewald CF, Sabatini M, et al. Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type 1 collagen mRNA in long tern cultures of fetal rat calvarial osteoblasts. J Bone Miner Res 1994; 9:855-863
29. Karsenty G. Genetics of skeletogenesis. Dev Genet 1998;22: 301-313
30. Piek E, Heldin CH, Ten Dijke P. Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J 1999;13: 2105-2124
31. Massague J. The transforming growth factor-beta family. Annu Rev Cell Biol 1990;6:597-641
32. Massague J. TGFβ signaling: receptors, transducers, and Mad proteins. Cell 1996;85:947-950
33. Carcamo J, Zentella A, Massague J. Disruption of transforming growth factor B signaling by a mutation that prevents transphosphorylation with the receptor complex. Mol Cell Biol 1995;15:1573-1581
34. Heldin CH, Miyazono K, Ten Dijke P. TGF-beta signaling from cell membrane to nucleus through SMAD proteins. Nature 1997;390:465-471
35. Wrana JL, Attisano L, Weiser R, et al. Mechanisms of activation of the TGF-B receptor. Nature 1994;370:341-347
36. Spector JA, Mehrara BJ, Greenwald J, et al. A molecular analysis of the isolated rat posterior frontal and sagittal sutures: differences in gene expression. Plast Reconstr Surg 2000;106:852-861
37. Mehrara BJ, Steinbrech DS, Saadeh PB, et al. Expression of high-affinity receptors for TGF-beta during rat cranial suture fusion. Ann Plast Surg 1999;42:502-508
38. Warren SM, Greenwald JA, Spector JA, et al. New developments in cranial suture research. Plast Reconstr Surg 2001; 107:523-540
39. Roth DA, Bradley JP, Levine JP, et al. Studies in cranial suture biology: Part II. Role of the dura in cranial suture fusion. Plast Reconstr Surg 1996;97:693-699
40. Levine JP, Bradley JP, Roth DA, et al. Studies in cranial suture biology: regional dura mater determines overlying suture biology. Plast Reconstr Surg 1998;101:1441-1447
41. Greenwald JA, Mehrara BJ, Spector JA, et al. Regional differentiation of cranial suture-associated dura mater in vivo and in vitro: implications for suture fusion and patency. J Bone Miner Res 2000;15:2413-2430
42. Warren SM, Brunet LJ, Harland RM, et al. The BMP antagonist noggin regulates cranial suture fusion. Nature 2003;422:625-629
43. Bahamonde ME, Lyons KM. BMP3: to be or not to be a BMP. J Bone Joint Surg Am 2001;83-A(Suppl 1):S56-S62
44. Faucheux C, Ulysse F, Bareille R, et al. Opposing actions of BMP3 and TGF beta 1 in human bone marrow stromal cell growth and differentiation. Biochem Biophys Res Commun 1997;241:787-793
45. Daluiski A, Engstrand T, Bahamonde ME, et al. Bone morphogenetic protein-3 is a negative regulator of bone density. Nat Genet 2001;27:84-88
46. Iseki S, Wilkie AOM, Heath JK, et al. Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2. Development 1997;124: 3375-3384
47. Iseki S, Wilkie AOM, Morriss-Kay GM. Fgfr1 and Fgfr2 have distinct differentiation-and proliferation-related roles in the developing mouse skull vault. Development 1999;126:5611-5620
48. Hunenko O, Karmacharya J, Ong G, et al. Toward an understanding of nonsyndromic craniosynostosis: altered patterns of TGF-beta receptor and FGF receptor expression induced by intrauterinehead constraint. Ann Plast Surg 2001;46:546-553
49. Gaudenz K, Roessler E, Vainikka S, et al. Analysis of patients with craniosynostosis syndromes for a pro246Arg mutation of FGFR4. Mol Genet Metab 1998;64:76-79
50. Greenwald JA, Mehrara BJ, Spector JA, et al. In vivo modulation of FGF-biologic activity alters cranial suture fate. Am J Pathol 2001;158:441-452
51. Mehrara BJ, Greenwald JA, Chin G, et al. Regional differentiation of rat cranial suture-derived dural cells is dependent on association with fusing and patent cranial sutures. Plast Reconstr Surg 1999;104:1003-1013
52. Opperman LA. Cranial sutures as intramembranous bone growth sites. Dev Dyn 2000;219:472-485
53. Opperman LA, Adab K, Gakunga PT. Transforming growth factor-beta 2 and TGF-beta 3 regulate fetal rat cranial suture morphogenesis by regulating rates of cell proliferation and apoptosis. Dev Dyn 2000;219:237-247
54. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003;113:685-700